Lexicon Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $34.3M | $66.7M | $22.5M | $46.3M | $64.1M | $126.3M | $36.1M | $80.4M |
| Accounts Receivable | $2.4M | $3.5M | $1.0M | $28.0K | $14.0K | $395.0K | $56.5M | $5.9M |
| Inventory | $281.0K | $231.0K | $381.0K | $0 | — | $0 | $4.2M | $4.7M |
| Total Current Assets | $101.9M | $246.2M | $176.5M | $140.9M | $88.9M | $157.7M | $337.8M | $173.3M |
| Property, Plant & Equipment | $1.9M | $2.5M | $2.0M | $2.1M | $1.2M | $295.0K | $14.0M | $15.9M |
| Goodwill | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | $19.7M | $21.5M |
| Total Assets | $185.0M | $298.4M | $229.4M | $194.3M | $136.9M | $203.8M | $417.7M | $284.1M |
| Liabilities | ||||||||
| Accounts Payable | $3.1M | $14.8M | $14.4M | $10.4M | $9.2M | $5.5M | $12.2M | $12.1M |
| Total Current Liabilities | $20.9M | $45.2M | $31.5M | $23.2M | $22.1M | $46.8M | $65.3M | $36.8M |
| Long-Term Debt | $49.4M | $100.3M | $99.5M | $48.6M | $0 | $0 | $234.2M | $243.9M |
| Total Liabilities | $77.4M | $152.5M | $136.3M | $77.2M | $23.3M | $47.4M | $300.6M | $310.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-2.02B | $-1.97B | $-1.77B | $-1.59B | $-1.49B | $-1.40B | $-1.34B | $-1.47B |
| Total Stockholders' Equity | $107.5M | $146.0M | $93.1M | $117.1M | $113.6M | $156.4M | $117.1M | $-26.4M |